The metabolic syndrome and renal function in an African cohort infected with human immunodeficiency virus
- PMID: 30349743
- PMCID: PMC6191676
- DOI: 10.4102/sajhivmed.v19i1.813
The metabolic syndrome and renal function in an African cohort infected with human immunodeficiency virus
Abstract
Introduction: The human immunodeficiency virus (HIV) is often accompanied by renal dysfunction. It is expected that metabolic syndrome (MetS) may exacerbate renal impairment.
Objective: We therefore determined the prevalence of MetS and the association thereof with renal function in a South African cohort infected with HIV.
Methods: We matched 114 HIV-infected (77.3% on antiretroviral therapy [ART] and 22.7% ART-naïve) and 114 HIV-uninfected individuals according to age, sex and locality. We examined cardiovascular, anthropometric and metabolic measurements and determined the MetS. Renal function was assessed using standardised procedures.
Results: The prevalence of MetS was lower in the HIV-infected individuals as compared to the uninfected individuals (28% vs. 44%, p = 0.013). The HIV-infected group presented with a lower body mass index (BMI) and waist circumference (WC) (all p < 0.001), as well as blood pressure (BP) (p ≤ 0.0021). The results were confirmed when comparing the HIV-infected group using ART (N = 85) and the HIV-uninfected group. When comparing the HIV-infected individuals with MetS to the HIV-uninfected individuals with MetS, no differences in BP were seen. With regard to renal function, the HIV-infected individuals with MetS (n = 32) had 43% higher urinary albumin-creatinine ratio (uACR) compared to the HIV-uninfected individuals with MetS, after adjusting for age, sex and WC (p = 0.032). None of the other renal function markers differed after adjustments for WC or BMI.
Conclusion: The HIV-infected Africans with MetS had almost twofold higher uACR, despite the low prevalence of MetS, compared to their uninfected counterparts. The combination of HIV and MetS seemed to increase the risk for renal impairment.
Conflict of interest statement
The authors declare that they have no financial or personal relationships that may have inappropriately influenced them in writing this article.
Figures
References
-
- Statistics South Africa Mid-year population estimates [homepage on the Internet]. 2015. [cited 2016 Apr 13]. Available from: https://www.statssa.gov.za/publications/P0302/P03022015.pdf
-
- World Health Organization Guideline on when to start antiretroviral therapy and on pre-exposure prophylaxis for HIV [homepage on the Internet]. 2015. [cited 2016 May 08]. Available from: www.who.int/hiv/pub/guidelines/earlyrelease-arv/en - PubMed
-
- Berhane T, Yami A, Alemseged F, et al. Prevalence of lipodystrophy and metabolic syndrome among HIV positive individuals on highly active anti-retroviral treatment in Jimma, South West Ethiopia. Pan Afr Med J [serial online]. 2013[cited 2018 Aug 16];13(1):1–4. Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3542806/pdf/PAMJ-13-43.pdf - PMC - PubMed
LinkOut - more resources
Full Text Sources